FOR IMMEDIATE RELEASE: 2023/9/12

M3 Acquires DrSanté, a Fast-Growing Practice Management Software in France

~ Strengthening M3's Position as a Leading Provider in Ambulatory Care ~

M3, Inc. (Headquarters: Tokyo, Japan; CEO: Itaru Tanimura; URL: https://corporate.m3.com/en/; "M3" below) has announced the acquisition via M3's European subsidiary VIDAL Group ("Vidal" below), of Calimaps SAS (Headquarters: Bordeaux, France; URL: https://www.logicieldrsante.com/; "Calimaps" below), the publisher of a fast-growing practice management software "DrSanté" for ambulatory care physicians in France.

  • Background and Overview of the Acquisition

M3 operates m3.com, a specialized web portal for medical professionals that delivers healthcare- related information to its 320,000+ physician members in Japan. Presence outside of Japan includes the U.S., U.K., France, China, Korea, and India, with aggressive business expansion overseas that has amassed 6.5 million physicians across its global platforms.

In France, M3 acquired Vidal in 2016, which provides prescription management software solutions. The drug database managed by Vidal is used by 75% of the physicians in France. In 2019, through Vidal, M3 also completed the acquisition of Weda, now the leading provider of cloud- based practice management software for the ambulatory care market. Over 20,000 healthcare professionals, including 12,000 physicians, use Weda on a daily basis.

Calimaps, a French software provider, launched DrSanté in 2016. DrSanté is a fast-growing practice management solution for ambulatory care and enables physicians to manage their patient records, prescribe safely, and connect to the French health insurance infrastructure. DrSanté is used daily by over 6,000 healthcare professionals, including 4,200 physicians. It is particularly popular among younger practitioners looking for a user-friendly solution with a sleek interface.

French practice management software market has been rapidly transitioning from on-premise software to cloud software. With this acquisition, M3 now owns 2 of the most popular practice management software in this fast-growing market segment.

  • Expected Synergies

Expected synergies between Vidal, Weda, and Calimaps include complementing current product features, sharing future complementary modules between these three solutions, such as telemedicine or AI-based efficiency tools, and strengthening the offerings. M3 will continue to contribute to solving practice management issues as a leading provider in ambulatory care while aiming for further growth.

Calimaps Overview

Company name: Calimaps SAS

Established: 1986

Headquarters: Bordeaux, France

URL:https://www.logicieldrsante.com/

CEO: Antoine Villalobos

Business: Practice management software for ambulatory care physicians

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

M3 Inc. published this content on 12 September 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 September 2023 06:11:04 UTC.